Renin angiotensin aldosterone inhibitors in the treatment of proteinuria in children with congenital anomalies of the kidney and urinary tract: more evidence needed.

MLA

Rivetti, Giulio, et al. “Renin Angiotensin Aldosterone Inhibitors in the Treatment of Proteinuria in Children with Congenital Anomalies of the Kidney and Urinary Tract: More Evidence Needed.” Expert Review of Clinical Pharmacology, vol. 16, no. 9, July 2023, pp. 791–98. EBSCOhost, https://doi.org/10.1080/17512433.2023.2247985.

APA

Rivetti, G., Gizzone, P., Di Sessa, A., Guarino, S., Miraglia Del Giudice, E., & Marzuillo, P. (2023). Renin angiotensin aldosterone inhibitors in the treatment of proteinuria in children with congenital anomalies of the kidney and urinary tract: more evidence needed. Expert Review of Clinical Pharmacology, 16(9), 791–798. https://doi.org/10.1080/17512433.2023.2247985

Chicago

Rivetti, Giulio, Pietro Gizzone, Anna Di Sessa, Stefano Guarino, Emanuele Miraglia Del Giudice, and Pierluigi Marzuillo. 2023. “Renin Angiotensin Aldosterone Inhibitors in the Treatment of Proteinuria in Children with Congenital Anomalies of the Kidney and Urinary Tract: More Evidence Needed.” Expert Review of Clinical Pharmacology 16 (9): 791–98. doi:10.1080/17512433.2023.2247985.